|
|
Volumn 14, Issue 3, 2008, Pages 399-405
|
|
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
a
|
|
Author keywords
Azathioprine; Cancer; Cyclophosphamide; Disease modifying therapies; Glatiramer acetate; Interferon beta; Mitoxantrone; Multiple sclerosis
|
|
Indexed keywords
AZATHIOPRINE;
BETA INTERFERON;
CYCLOPHOSPHAMIDE;
GLATIRAMER;
IMMUNOMODULATING AGENT;
METHOTREXATE;
MITOXANTRONE;
ACUTE LEUKEMIA;
ADULT;
AGE;
ARTICLE;
BLADDER CANCER;
BREAST CANCER;
CANCER INCIDENCE;
CANCER RISK;
CONTROLLED STUDY;
DIGESTIVE SYSTEM CANCER;
DISEASE ASSOCIATION;
DRUG EXPOSURE;
FEMALE;
FRANCE;
GYNECOLOGIC CANCER;
HEALTH CARE FACILITY;
HISTOPATHOLOGY;
HUMAN;
INFORMATION PROCESSING;
KIDNEY CANCER;
LUNG CANCER;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MULTIPLE SCLEROSIS;
NERVOUS SYSTEM TUMOR;
RISK REDUCTION;
SEX DIFFERENCE;
SKIN CANCER;
TREATMENT OUTCOME;
ADULT;
AZATHIOPRINE;
BREAST NEOPLASMS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
CYCLOPHOSPHAMIDE;
DIGESTIVE SYSTEM NEOPLASMS;
FEMALE;
GENITAL NEOPLASMS, FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
INTERFERON-BETA;
LEUKEMIA;
LYMPHOMA;
MALE;
MIDDLE AGED;
MITOXANTRONE;
MULTIPLE SCLEROSIS;
NEOPLASMS;
PEPTIDES;
REGISTRIES;
RISK FACTORS;
SKIN NEOPLASMS;
UROLOGIC NEOPLASMS;
|
|
EID: 43549121686
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1177/1352458507083625 Document Type: Article |
|
Times cited : (94)
|
|
References (51)
|
